Nutex Health (NASDAQ:NUTX) Trading 7.9% Higher - Here's What Happened

Key Points

• Nutex Health's stock price increased by 7.9%, reaching a last traded price of $103.73, following a prior close of $96.12.
• Analysts have shown optimism for Nutex Health, with Benchmark raising their price target to $300 and Maxim Group to $225, both giving "buy" ratings.
• The company's latest earnings report revealed an EPS of $2.56, significantly beating expectations, along with substantial revenue of $211.79 million for the quarter.

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report)'s stock price was up 7.9% on Wednesday . The company traded as high as $105.50 and last traded at $103.73. Approximately 80,111 shares changed hands during mid-day trading, a decline of 44% from the average daily volume of 143,177 shares. The stock had previously closed at $96.12.

Analyst Ratings Changes

Several analysts have weighed in on NUTX shares. Benchmark boosted their price objective on Nutex Health from $150.00 to $300.00 and gave the company a "buy" rating in a research report on Thursday, May 15th. Maxim Group lifted their price target on Nutex Health from $100.00 to $225.00 and gave the stock a "buy" rating in a research report on Tuesday, May 20th. Finally, Wall Street Zen cut shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 22nd.

Nutex Health Trading Up 9.2%

The stock's 50-day simple moving average is $110.57 and its two-hundred day simple moving average is $99.40. The company has a debt-to-equity ratio of 1.02, a current ratio of 2.27 and a quick ratio of 2.26. The firm has a market capitalization of $583.83 million, a P/E ratio of 8.83 and a beta of 0.05.

Nutex Health (NASDAQ:NUTX - Get Free Report) last announced its quarterly earnings data on Tuesday, May 13th. The company reported $2.56 EPS for the quarter, beating the consensus estimate of ($0.15) by $2.71. The business had revenue of $211.79 million for the quarter, compared to the consensus estimate of $81.09 million. Nutex Health had a return on equity of 42.08% and a net margin of 10.76%.

Institutional Investors Weigh In On Nutex Health

Institutional investors have recently added to or reduced their stakes in the stock. New York State Common Retirement Fund bought a new position in shares of Nutex Health during the second quarter worth $137,000. Quadrature Capital Ltd bought a new position in shares of Nutex Health during the 2nd quarter valued at about $1,109,000. State Board of Administration of Florida Retirement System bought a new position in shares of Nutex Health during the 2nd quarter valued at about $266,000. XTX Topco Ltd purchased a new position in shares of Nutex Health during the second quarter valued at about $208,000. Finally, CreativeOne Wealth LLC bought a new stake in shares of Nutex Health in the second quarter worth about $434,000. 5.32% of the stock is owned by hedge funds and other institutional investors.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.